Medical Care Costs Associated with Cancer Survivorship in the United States.

ABSTRACT:

Background

The prevalence of cancer survivorship is increasing. In this study, we provide contemporary population-based estimates and projections of the overall and site-specific cancer-attributable medical care costs in the United States.

Methods

We identified survivors aged ≥65 years diagnosed with cancer between 2000 and 2012 from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database and used 2007 to 2013 claims to estimate costs by cancer site, phases of care, and stage at diagnosis. Annualized average cancer-attributable costs for medical care (Medicare Parts A and B) and oral prescription drugs (Medicare Part D) were estimated by subtracting costs between patients with cancer and matched controls. Costs are reported in 2019 U.S. dollars. We combined

SUBMITTER: Mariotto AB 

PROVIDER: S-EPMC9514601 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature